Utilização de medicamentos na gravidez: Risco e benefício

Abstract

During pregnancy the woman and her baby are exposed to risks, among them, those arising from the use of medications. Their use in this period can occur inappropriately, being a problem in the field of public health. The research aimed to verify the use of medications by pregnant patients seen in primary care in the city of Capistrano, Ceará, as well as their knowledge regarding the teratogenic risks of the use of drugs in pregnancy. The study was observational, descriptive, transversal, being a situational survey with a predominantly quantitative approach, developed from September to October 2019, with data obtained through individual interviews, which made it possible to fill in a semi-structured form. Fifty pregnant women participated in the research, where 88% used medicines, with 11 different types being mentioned, belonging to classes A and B of teratogenic risk. 62% of pregnant women had already received some guidance regarding the use of medications, and only 52% had real knowledge about the risks. Further education in permanent health within the UBS is essential, increasing the professional-patient bond, in addition to the inclusion of the pharmacist in the multidisciplinary team, promoting the rational use of medications and reducing the risks of possible complications during this period.